VanEck Pharmaceutical ETF Rating $86.54 -0.40 (-0.46%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrends VanEck Pharmaceutical ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PPH Aggregate RatingModerate Buy 2.70Holdings in PPH have an aggregate rating of Moderate Buy based on 268 analyst ratings issued in the past year covering 24 companies (95.3% of the portfolio).PPH Aggregate Price Target$86.54High Prediction$86.54Average Prediction$86.54Low Prediction$86.54Holdings in PPH have an aggregate price target of $86.54 and a range of $86.54 to $86.54 covering 24 companies (95.3% of the portfolio).PPH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy12 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by VanEck Pharmaceutical ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 24 PPH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings12.61%LLYEli Lilly and Company$767.76+1.3%4.9956 of 5 stars2.81$1,002.22 30.5%21Gap UpHigh Trading Volume8.05%NVONovo Nordisk A/S$85.00-17.8%3.7254 of 5 stars3.00$150.40 76.9%7Analyst UpgradeNews CoverageGap DownHigh Trading Volume6.36%JNJJohnson & Johnson$144.47+0.6%4.8952 of 5 stars2.50$174.73 20.9%14High Trading Volume5.86%ABBVAbbVie$175.58+2.4%4.9342 of 5 stars2.88$205.70 17.2%24Analyst ForecastInsider TradeHigh Trading Volume5.86%BMYBristol-Myers Squibb$57.33+1.8%4.7872 of 5 stars2.25$55.64 -2.9%20High Trading Volume5.76%MCKMcKesson$579.74+0.1%4.9579 of 5 stars2.94$650.14 12.1%16Analyst ForecastHigh Trading Volume5.01%CORCencora$227.69+0.6%4.72 of 5 stars2.82$275.60 21.0%114.94%MRKMerck & Co., Inc.$98.05-1.5%4.9889 of 5 stars2.71$127.13 29.7%21Analyst DowngradeHigh Trading Volume4.78%NVSNovartis$97.11+0.4%3.6525 of 5 stars1.78$121.50 25.1%94.51%HLNHaleon$9.69-0.1%3.3454 of 5 stars3.00$10.95 13.0%6Positive News4.51%AZNAstraZeneca$65.35+1.4%4.0461 of 5 stars2.91$89.75 37.3%114.45%ZTSZoetis$164.84+0.8%4.6044 of 5 stars3.09$215.22 30.6%11High Trading Volume4.19%PFEPfizer$26.36+2.3%4.9837 of 5 stars2.47$32.14 21.9%17Analyst ForecastOptions VolumeAnalyst RevisionHigh Trading Volume4.09%SNYSanofi$47.71+0.4%3.556 of 5 stars3.00$57.50 20.5%33.82%GSKGSK$33.60+0.5%4.0844 of 5 stars2.60$43.25 28.7%10Analyst Downgrade3.79%TEVATeva Pharmaceutical Industries$22.09+3.7%1.8758 of 5 stars2.75$20.88 -5.5%8Analyst DowngradeOptions VolumeNews Coverage2.17%VTRSViatris$12.52+3.2%2.056 of 5 stars2.00$13.67 9.2%3News CoverageHigh Trading Volume1.16%CTLTCatalent$63.482.7663 of 5 stars2.00$63.40 -0.1%71.11%JAZZJazz Pharmaceuticals$122.97+0.1%4.8529 of 5 stars2.87$177.00 43.9%15High Trading Volume0.56%ELANElanco Animal Health$11.63-1.6%3.7792 of 5 stars2.25$16.71 43.7%80.56%OGNOrganon & Co.$14.58+1.0%4.8014 of 5 stars2.50$21.33 46.3%4High Trading Volume0.50%PRGOPerrigo$25.75+0.1%4.9867 of 5 stars2.75$37.00 43.7%4Positive News0.42%BHCBausch Health Companies$7.47+1.1%2.8422 of 5 stars2.00$7.75 3.7%7Analyst Revision0.25%PDCOPatterson Companies$30.86-0.2%4.1453 of 5 stars2.09$26.57 -13.9%11Analyst ForecastHigh Trading Volume This page (NASDAQ:PPH) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Pharmaceutical ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Pharmaceutical ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
